ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important

  • NEW YORK CITY, NY / ACCESS Newswire / June 15, 2025 / WHY: New York, N.Y., June 15, 2025.